Drug recall · September 2, 2026
Paxil CR recall
Why: Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-4379-3
- Lots / codes
Lot # TY9494, Exp Date: 05/31/2027.
- Quantity
- 6,972 bottles
- Company
- Apotex Corp., Weston, FL
- Distribution
- US Nationwide.
- Initiated
- August 13, 2026 · Voluntary: Firm initiated
- Classified
- August 27, 2026
- Reported
- September 2, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Paroxetine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.